DOW Tanks as Healthcare Stocks Nosedive—Trump’s Order Outpaces Broader Market Rally

Wall Street’s supposed ’rally’ couldn’t save the DOW from hemorrhaging points—thanks to healthcare stocks getting gutted by the latest presidential decree. The irony? The S&P and Nasdaq still moonwalked into green territory. Classic market ’logic.’

Active verbs only? Try ’plummeted,’ ’slashed,’ and ’defied.’ No room for passive voice when billions vanish faster than a crypto trader’s margin call.

And here’s your finance jab: Another day, another case of ’diversification’ working perfectly—unless you picked the wrong sector. Maybe try Bitcoin next time?

Healthcare stocks hammered by Trump’s new move

Still, gains from Nvidia and Amazon were outweighed by Microsoft’s loss of 0.28%, as well as significant losses from healthcare firms. For instance, Johnson & Johnson lost 3.04%, while Merck lost 3.18%, both companies involved in healthcare.

What is more, UnitedHealth lost an astonishing 16.34% after an abrupt exit by its long-time CEO, Andrew Witty. The company also suspended its annual price forecast, citing rising medical costs for the decision.

Health care stocks have been on the decline after U.S. President Donald TRUMP signed an executive order aimed at slashing prescription drug prices. The administration directed companies to cut drug prices to similar levels to what patients in other countries are paying. For those that don’t comply, the White House has threatened escalating, yet unspecified measures to keep them in line.

Analysts estimated that cutting drug prices in the U.S. could cut 2028 net income for the world’s pharmaceutical industry by 8%. Still, while the move WOULD cut into the profits of healthcare firms, it might bring relief to Americans struggling with rising healthcare costs.